Walleye Trading Advisors »

Bridgebio Pharma shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $980k 32k 30.92
2023-09-30 $1.7M 65k 26.37
2023-06-30 $1.8M 107k 17.20
2023-03-31 $280k 17k 16.58
2021-12-31 $883k 53k 16.68
2021-03-31 $256k 4.2k 61.60

More positions owned by Walleye Trading Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Tesla Motors Call Option (TSLA)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Select Sector Spdr Tr Financial Call Option (XLF)
Advanced Micro Devices Call Option (AMD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)

View all positions for Walleye Trading Advisors

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Laurion Capital Management
Henderson Group
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Alliancebernstein
Goldman Sachs Group
Cormorant Asset Management

View all funds holding Bridgebio Pharma